Skip to main content
Home / Die Pharmazie - An International Journal of Pharmaceutical Sciences, Volume 60, Number 10

Open Access Topical delivery of retinyl ascorbate co-drug: 6. Determination of toxic dose and antioxidant activity in cultured human epidermal keratinocytes

Download Article:
The maximum effective dose of retinyl ascorbate and its potential therapeutic benefits against induced oxidative damage were assessed in vitro using cultured human epidermal keratinocytes. RA-AsA exhibited toxic effects at concentrations >6 μM. The findings indicate to the potency of RA-AsA as free radical scavenger and cell proliferation regulator.

Document Type: Short Communication

Affiliations: 1: Welsh School of Pharmacy, Cardiff University, Cardiff, UK 2: Welsh School of Pharmacy, Cardiff University, Strasse, Cardiff, CF10 3XF, UK, Email: [email protected]

Publication date: October 1, 2005

More about this publication?

  • Pharmazie is a leading journal in the field of pharmaceutical sciences. As a peer-reviewed scientific journal, Pharmazie is regularly indexed in the relevant databases like Web of science, Journal Citation Reports and many others. The journal is open for submissions from the whole spectrum of pharnaceutical sciences including Pharmaceutical Chemistry, Experimental and Clinical Pharmacology, Drug Analysis, Pharmaceutics, Pharmaceutical Biology, Clinical Pharmacy etc.

    Starting from Volume 81 Issue 1 (2026), Die Pharmazie (Print ISSN: 0031-7144 | Electronic ISSN: 3053-691X) will be published by IMR Press . https://www.imrpress.com/journal/Pharmazie.

    Avoxa - Mediengruppe Deutscher Apotheker GmbH will no longer be accepting submissions. Authors can make a new submission through the Propub system .https://imr.propub.com/access/login

  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content